Insider Trading Alert - PLUG, UNP, OPK, ISIS And MA Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Jan. 24, 2014, 63 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $199.71 to $33,314,419.42.

Highlighted Stocks Traded by Insiders:

Plug Power (PLUG) - FREE Research Report

Air Liquide Investissements d'Avenir et de Demonstration who is Director at Plug Power sold 24,836 shares at $1.63 on Jan. 24, 2014. Following this transaction, the Director owned 39,324 shares meaning that the stake was reduced by 38.71% with the 24,836-share transaction.

The shares most recently traded at $2.91, up $1.28, or 43.82% since the insider transaction. Historical insider transactions for Plug Power go as follows:

  • 12-Week # shares bought: 32,218
  • 24-Week # shares bought: 32,218

The average volume for Plug Power has been 17.2 million shares per day over the past 30 days. Plug Power has a market cap of $327.1 million and is part of the technology sector and electronics industry. Shares are up 80.97% year-to-date as of the close of trading on Friday.

Plug Power Inc., an alternative energy technology provider, engages in the design, development, commercialization, and manufacture of fuel cell systems for the industrial off-road markets worldwide. Currently there are 2 analysts that rate Plug Power a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PLUG - FREE

TheStreet Quant Ratings rates Plug Power as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and disappointing return on equity. Get the full Plug Power Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Union Pacific (UNP) - FREE Research Report

Totusek Jeffrey P who is Vp Controller & Cao Upc at Union Pacific sold 1,028 shares at $172.75 on Jan. 24, 2014. Following this transaction, the Vp Controller & Cao Upc owned 55,360 shares meaning that the stake was reduced by 1.82% with the 1,028-share transaction.

The shares most recently traded at $172.01, down $0.74, or 0.43% since the insider transaction. Historical insider transactions for Union Pacific go as follows:

  • 4-Week # shares sold: 1,224
  • 12-Week # shares sold: 15,386
  • 24-Week # shares sold: 25,386

The average volume for Union Pacific has been 2.0 million shares per day over the past 30 days. Union Pacific has a market cap of $80.2 billion and is part of the services sector and transportation industry. Shares are up 2.17% year-to-date as of the close of trading on Friday.

Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, provides rail transportation services in North America. The stock currently has a dividend yield of 1.81%. The company has a P/E ratio of 18.5. Currently there are 13 analysts that rate Union Pacific a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UNP - FREE

TheStreet Quant Ratings rates Union Pacific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Union Pacific Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 14,900 shares at $8.82 on Jan. 24, 2014. Following this transaction, the CEO & Chairman owned 137.9 million shares meaning that the stake was reduced by 0.01% with the 14,900-share transaction.

The shares most recently traded at $8.35, down $0.47, or 5.65% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 46,730
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 46,730
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 46,730

The average volume for Opko Health has been 4.4 million shares per day over the past 30 days. Opko Health has a market cap of $3.6 billion and is part of the health care sector and health services industry. Shares are up 0.24% year-to-date as of the close of trading on Friday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Isis Pharmaceuticals (ISIS) - FREE Research Report

Wender Joseph H who is Director at Isis Pharmaceuticals sold 10,000 shares at $50.98 on Jan. 24, 2014. Following this transaction, the Director owned 31,135 shares meaning that the stake was reduced by 24.31% with the 10,000-share transaction.

The shares most recently traded at $47.46, down $3.52, or 7.42% since the insider transaction. Historical insider transactions for Isis Pharmaceuticals go as follows:

  • 4-Week # shares sold: 362
  • 12-Week # shares sold: 21,093
  • 24-Week # shares sold: 25,987

The average volume for Isis Pharmaceuticals has been 1.2 million shares per day over the past 30 days. Isis Pharmaceuticals has a market cap of $5.8 billion and is part of the health care sector and drugs industry. Shares are up 21.54% year-to-date as of the close of trading on Friday.

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. Currently there are 4 analysts that rate Isis Pharmaceuticals a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ISIS - FREE

TheStreet Quant Ratings rates Isis Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Isis Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

MasterCard Incorporated (MA) - FREE Research Report

MasterCard Foundation who is 10% Owner at MasterCard Incorporated sold 404,760 shares at $82.31 on Jan. 24, 2014. Following this transaction, the 10% Owner owned 120.4 million shares meaning that the stake was reduced by 0.33% with the 404,760-share transaction.

The shares most recently traded at $77.66, down $4.65, or 5.98% since the insider transaction. Historical insider transactions for MasterCard Incorporated go as follows:

  • 4-Week # shares sold: 26,984
  • 12-Week # shares sold: 29,854
  • 24-Week # shares sold: 34,136

The average volume for MasterCard Incorporated has been 6.7 million shares per day over the past 30 days. MasterCard Incorporated has a market cap of $95.4 billion and is part of the financial sector and financial services industry. Shares are down 5.97% year-to-date as of the close of trading on Friday.

MasterCard Incorporated, together with its subsidiaries, provides transaction processing and other payment-related services in the United States and internationally. The stock currently has a dividend yield of 0.53%. The company has a P/E ratio of 32.5. Currently there are 17 analysts that rate MasterCard Incorporated a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MA - FREE

TheStreet Quant Ratings rates MasterCard Incorporated as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, increase in net income, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full MasterCard Incorporated Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Credit Suisse Surges After Strong Q1, Record Wealth Management Inflows

Credit Suisse Surges After Strong Q1, Record Wealth Management Inflows

Global Stocks Slide as Yield Pressure, Commodity Surge Prompts Equity Exit

Global Stocks Slide as Yield Pressure, Commodity Surge Prompts Equity Exit

Asian Markets Decline in Morning Trading

Asian Markets Decline in Morning Trading

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday